Last reviewed · How we verify
NCT03090217: PPPVSSR
Pelvic Physiotherapy in the Prevention of Vaginal Stenosis Secondary to the Radiotherapy
NA trial testing Pelvic Physiotherapy in Gynecologic Cancer in 160 participants. Status unknown.
31 May 2018
Quick facts
| Lead sponsor | Federal University of Health Science of Porto Alegre |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 160 |
| Start date | 21 August 2017 |
| Primary completion | 31 May 2018 |
| Estimated completion | 31 July 2018 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Pelvic Physiotherapy
- Standard care (SC)
Conditions studied
- Gynecologic Cancer — all drugs for Gynecologic Cancer →
- Pathological Constriction — all drugs for Pathological Constriction →
Sponsor
Federal University of Health Science of Porto Alegre
Who can join
18 and older, female only, with Gynecologic Cancer or Pathological Constriction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Vaginal stenosis is one of the most prevalent side effects of pelvic radiation, affecting about one third of women. In this randomized controlled trial, the effect of a pelvic physiotherapy protocol on an incidence rate of vaginal stenosis in women with gynecological cancer undergoing gynecological brachytherapy. In addition, the investigators will explore an improvement in quality of life, sexuality, and contractile function of the pelvic floor muscles.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Clinical and Psychological Outcomes of the Use of Vaginal Dilators After Gynaecological Brachytherapy: a Randomized Clinical Trial.
Cerentini TM, Schlöttgen J, Viana da Rosa P, La Rosa VL, et al · · 2019 · cited 20× · PMID 31209699 · DOI 10.1007/s12325-019-01006-4
Verify or expand the search:
- PubMed search for NCT03090217
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gynecologic Cancer
Currently open trials in the same condition.
- NCT07524114 — Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception · recruiting
- NCT07408349 — Guided Imagery of the Gynecological Cancer · NA · recruiting
- NCT07447050 — Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial · Phase 2 · recruiting
- NCT07173101 — Clinical Investigation of the Effects of Semiconductor Embedded Therapeutic Garments on Cancer-related Cognitive Impairm · Phase 2 · recruiting
- NCT07166042 — Guided Meditation During Radiation Therapy for Breast and Gynecological Malignancies · Phase 3 · recruiting
Other Federal University of Health Science of Porto Alegre trials
Trials by the same sponsor.
- NCT07432113 — Prediction of Infectious Agents in the Biofire® FilmArray bioMérieux Meningitis/Encephalitis Panel Based on Clinical Syn · NA · not yet recruiting
- NCT07232862 — Analysis Of The Effect Of A Fine Manual Skills Intervention In A Specific Context On The Linguistic Processing of Health · NA · recruiting
- NCT07172698 — Effects of a Multicomponent Protocol With Emphasis on Muscle Power Training on Bradykinesia in Individuals With Parkinso · NA · completed
- NCT06761963 — Chronic Effect of Whole-body Electrical Stimulation in COPD Patients · NA · not yet recruiting
- NCT05814432 — Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS · Phase 3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03090217 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Federal University of Health Science of Porto Alegre
- Last refreshed: 22 August 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03090217.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing